Seeking Alpha May 22, 2026 • 10:47

Weight-loss drugs from Lilly, Novo linked to stalling cancer: report - Seeking Alpha

By Arundhati Sarkar

Weight-loss drugs from Lilly, Novo linked to stalling cancer: report - Seeking Alpha

New studies link GLP-1 drugs like Ozempic and Mounjaro to lower cancer progression and death risk, including breast cancer benefits—learn what the data...

The Good Brigade
The worlds most popular weight-loss and diabetes drugs are linked to a powerful new possible benefit: better outcomes for cancer patients. A suite of four new studies suggests that … [+58 chars]

More from Seeking Alpha